Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Ante Strikić

41464

Ante

Strikić

nije evidentirano
Naziv Akcije
strikic, ante Differential expression of HIF1A and its downstream target VEGFA in the main subtypes of renal cell carcinoma and their impact on patient survival // Frontiers in oncology, 2023 Nov 20 (2023), 1; 1-9. doi: 10.3389/fonc.2023.1287239
Kokeza, Josipa; Strikić, Ante; Ogorevc, Marin; Kelam, Nela; Vukoja, Martina; Dilber, Ivo; Zekić Tomaš, Sandra; The Effect of GLUT1 and HIF-1α Expressions on Glucose Uptake and Patient Survival in Non-Small-Cell Lung Carcinoma // International journal of molecular sciences, 24 (2023), 13; 10575, 14
Ogorevc, Marin ; Strikic, Ante ; Zekic Tomas, Sandra Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method // Biomedical reports, 15 (2021), 4; 79-79. doi: 10.3892/br.2021.1455
Saratlija Novaković, Žana ; Boban, Toni ; Boraska Jelavić, Tihana ; Omrčen, Tomislav ; Šitum, Marijan ; Ledina, Dubravka ; Strikić, Ante ; Rakuljić, Zdravka ; Vilović, Katarina ; Librenjak, Davor et al. Results of treatment of muscle-invasive bladder cancer in University Hospital of Split: 2014-2021 // Libri oncologici : Croatian journal of oncology. 2021. str. 125-125
Majić, Ana ; Urlić, Ivan ; Pancirov, Marija ; Paparella - Karaman, Ana ; Strikić, Ante ; Ban, Marija ; Hrepić, Darijo ; Vrdoljak, Eduard Hematotoxicity od cyclin dependent kynases 4/6 (CDK4/6) inhibitors palbociclib and ribocyclib during first 2 cycles of treatment of metastatic breast cancer – a restropective analysis in single centre // Libri oncologici : Croatian journal of oncology. 2020. str. 99-99
Ban, Marija ; Strikić, Ante ; Petrić Miše, Branka ; Vrdoljak, Eduard Uloga inhibitora CDK4/6 u liječenju hormonski ovisnoga metastatskog raka dojke negativnog na HER2 // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 141 (2019), 1-2; 33-39. doi: 10.26800/lv-141-1-2-6
Ban, Marija ; Bajić, Željko ; Buljubašić, Matea ; Dražić, Ivanka ; Petrić Miše, Branka ; Strikić, Ante ; Božić, Maja, Ledina, Dubravka ; Vrdoljak, Eduard Correlation of the progression free survival after 1st treatment line (PFS1) with overall survival (OS) changes in metastatic breast cancer (MBC): Retrospective cohort study. 2018. str. 53-57
Klinička onkologija, 3. obnovljeno i dopunjeno izdanje / Vrdoljak, Eduard ; Belac Lovasić, Ingrid ; Kusić, Zvonko et al. (ur.) Zagreb: Medicinska naklada, 2018
Ban, Marija ; Dražić, Ivanka ; Buljubašić, Matea ; Bajić, Željko ; Petrić Miše, Branka ; Strikić, Ante ; Božić, Maja ; Ledina, Dubravka ; Vrdoljak, Eduard Differences in the overall survival (OS) of primary and secondary metastatic breast cancer (MBC) patients: A retrospective study. 2018. str. 50-52
Ban, Marija ; Viculin, Jelena ; Tomić, Snježana ; Čapkun, Vesna ; Strikić, Ante ; Petrić Miše, Branka ; Utrobičić, Ivo ; Vrdoljak, Eduard Retrospective analysis of efficacy of trastuzumab in adjuvant treatment of HER 2 positive early breast cancer – single institution experience // 12th Central European Oncology Congress: Abstract Book. -: -, 2016. str. 75-75
nije evidentirano
nije evidentirano